153 related articles for article (PubMed ID: 31790410)
1. Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study.
Yoon JY; Sy K; Brezden-Masley C; Streutker CJ
PLoS One; 2019; 14(12):e0224812. PubMed ID: 31790410
[TBL] [Abstract][Full Text] [Related]
2. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
Nshizirungu JP; Bennis S; Mellouki I; Sekal M; Benajah DA; Lahmidani N; El Bouhaddouti H; Ibn Majdoub K; Ibrahimi SA; Celeiro SP; Viana-Pereira M; Munari FF; Ribeiro GG; Duval V; Santana I; Reis RM
Dis Markers; 2021; 2021():9980410. PubMed ID: 34367379
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population.
Wang Q; Xie Q; Liu Y; Guo H; Ren Y; Li J; Zhao Q
Mol Med Rep; 2020 Aug; 22(2):828-840. PubMed ID: 32468041
[TBL] [Abstract][Full Text] [Related]
4. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery.
Ramos MFKP; Pereira MA; de Mello ES; Cirqueira CDS; Zilberstein B; Alves VAF; Ribeiro-Junior U; Cecconello I
World J Clin Oncol; 2021 Aug; 12(8):688-701. PubMed ID: 34513602
[TBL] [Abstract][Full Text] [Related]
5. Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes.
Angerilli V; Pennelli G; Galuppini F; Realdon S; Fantin A; Savarino E; Farinati F; Mastracci L; Luchini C; Fassan M
Virchows Arch; 2022 Oct; 481(4):545-552. PubMed ID: 35925389
[TBL] [Abstract][Full Text] [Related]
6. Molecular subtyping of gastric cancer according to ACRG using immunohistochemistry - Correlation with clinical parameters.
Pretzsch E; Bösch F; Todorova R; Nieß H; Jacob S; Guba M; Kirchner T; Werner J; Klauschen F; Angele MK; Neumann J
Pathol Res Pract; 2022 Mar; 231():153797. PubMed ID: 35151032
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications.
Koh J; Lee KW; Nam SK; Seo AN; Kim JW; Kim JW; Park DJ; Kim HH; Kim WH; Lee HS
Oncologist; 2019 Dec; 24(12):e1321-e1330. PubMed ID: 31371521
[TBL] [Abstract][Full Text] [Related]
8. Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
Huang SC; Ng KF; Yeh TS; Cheng CT; Lin JS; Liu YJ; Chuang HC; Chen TC
Int J Cancer; 2019 Dec; 145(12):3218-3230. PubMed ID: 30771224
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
Gonzalez RS; Messing S; Tu X; McMahon LA; Whitney-Miller CL
Hum Pathol; 2016 Oct; 56():16-21. PubMed ID: 27342907
[TBL] [Abstract][Full Text] [Related]
11. Bridging genomics and phenomics of gastric carcinoma.
Cho J; Ahn S; Son DS; Kim NK; Lee KW; Kim S; Lee J; Park SH; Park JO; Kang WK; An JY; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kim KM
Int J Cancer; 2019 Nov; 145(9):2407-2417. PubMed ID: 30801717
[TBL] [Abstract][Full Text] [Related]
12. Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features.
Hissong E; Ramrattan G; Zhang P; Zhou XK; Young G; Klimstra DS; Shia J; Fernandes H; Yantiss RK
Am J Surg Pathol; 2018 Apr; 42(4):453-462. PubMed ID: 29438172
[TBL] [Abstract][Full Text] [Related]
13. Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases.
Bösch F; Todorova R; Link H; Westphalen CB; Boeck S; Heinemann V; Werner J; Kirchner T; Angele MK; Neumann J
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2689-2697. PubMed ID: 31541339
[TBL] [Abstract][Full Text] [Related]
14. Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer.
Kohlruss M; Krenauer M; Grosser B; Pfarr N; Jesinghaus M; Slotta-Huspenina J; Novotny A; Hapfelmeier A; Schmidt T; Steiger K; Gaida MM; Reiche M; Bauer L; Ott K; Weichert W; Keller G
Br J Cancer; 2021 Dec; 125(12):1621-1631. PubMed ID: 34671125
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis.
Kang HJ; Lee IS; Park YS; Ho WJ; Sohn D; Ahn JY; Yook JH; Kim BS
Ann Surg Oncol; 2016 Oct; 23(11):3684-3692. PubMed ID: 27221363
[TBL] [Abstract][Full Text] [Related]
16. Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients.
Kim Y; Cho MY; Kim J; Kim SN; Oh SC; Lee KA
Oncotarget; 2017 Sep; 8(41):69888-69905. PubMed ID: 29050249
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.
Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS
Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752
[TBL] [Abstract][Full Text] [Related]
18. Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network.
Sunakawa Y; Lenz HJ
Curr Treat Options Oncol; 2015 Apr; 16(4):17. PubMed ID: 25813036
[TBL] [Abstract][Full Text] [Related]
19. Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm.
Park CK; Park JS; Kim HS; Rha SY; Hyung WJ; Cheong JH; Noh SH; Lee SK; Lee YC; Huh YM; Kim H
Oncotarget; 2016 Nov; 7(44):72099-72112. PubMed ID: 27765925
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project.
Sohn BH; Hwang JE; Jang HJ; Lee HS; Oh SC; Shim JJ; Lee KW; Kim EH; Yim SY; Lee SH; Cheong JH; Jeong W; Cho JY; Kim J; Chae J; Lee J; Kang WK; Kim S; Noh SH; Ajani JA; Lee JS
Clin Cancer Res; 2017 Aug; 23(15):4441-4449. PubMed ID: 28747339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
